IP Library Granted Patent US 7,771,745
Granted Patent B2
US 7,771,745 · App. 10/836,331 · Granted Aug 10, 2010

Fast dissolving tablet and method of preparing the same

Assignee: Pharmaceutical Industry Technology and Development Center
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,771,745
App. No.
10/836,331
Granted
Aug 10, 2010
Kind
B2
Abstract

The present invention provides a method for making a fast dissolving tablet. The method includes the steps of (a) preparing a first solution containing a hydrophilic polymer and a starch; (b) preparing a second solution containing a pharmaceutically active ingredient and a surfactant; (c) blending the first and the second solution together to form a plurality of granule powders by granulation; (d) mixing the granule powders with excipients; and (e) applying a compression-molding process to form the fast dissolving tablet.

Claims (23)

1. A method for preparing a fast dissolving tablet, comprising:

preparing a powdery first solution which comprises a hydrophilic polymer and a starch;

preparing a second solution which comprises a pharmaceutically active ingredient and a surfactant;

blending the first and second solutions to form a plurality of granule powders by a granulating process;

mixing the granule powders with at least an excipient; and

applying a compression-molding process to form the fast dissolving tablet; wherein the compression-molding process applies a pressure of about 800˜1200 lb/cm 2 , wherein the tablet has a porosity of about 30˜70%, and wherein the tablet has a disintegration time of less than 1 minute.

2. The method as claimed in claim 1 , wherein the hydrophilic polymer comprises PEG, PVP, carbopol, polysaccharide, agar, MC, or HPMC.

3. The method as claimed in claim 1 , wherein the surfactant comprises edible surfactant.

4. The method as claimed in claim 1 , wherein the surfactant comprises lecithin.

5. The method as claimed in claim 1 , wherein the solvent used in the first solution and second solution is H 2 O or ethanol.

6. The method as claimed in claim 1 , wherein the granulating process comprises dry granulation, wet granulation, fluidized bed granulation, or spray granulation.

7. The method as claimed in claim 1 , wherein the diameter of the granule powders is about 300˜500 μm.

8. The method as claimed in claim 1 , wherein the excipient is a disintegrating agent, an effervescent, a lubricant, or a sweetener.

9. The method as claimed in claim 1 , wherein the excipient comprises a saccharide, an alcohol, or a sugar alcohol.

10. The method as claimed in claim 9 , wherein the saccharide is a monosaccharide or a disaccharide.

11. The method as claimed in claim 9 , wherein the sugar alcohol is mannitol, sorbitol, xylitol, or glycerol.

12. The method as claimed in claim 1 , wherein the compression-molding process uses a speed of about 15˜20 rpm.

13. The method as claimed in claim 1 , wherein the pharmaceutically active ingredient is 5˜45% by weight of the fast dissolving tablet.

14. The method as claimed in claim 1 , wherein the starch is 20˜30% by weight of the fast dissolving tablet.

15. The method as claimed in claim 1 , wherein the hydrophilic polymer is 2˜10% by weight of the fast dissolving tablet.

16. The method as claimed in claim 1 , wherein the surfactant is 2˜10% by weight of the fast dissolving tablet.

17. The method as claimed in claim 1 , wherein the excipient is 40˜50% by weight of the fast dissolving tablet.

18. The method as claimed in claim 8 , wherein the lubricant is 1˜3% by weight of the fast dissolving tablet.

Assignments (2)
CHANGE OF NAME Recorded Sep 21, 2010
From: PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER
To: MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER
Reel/Frame 025017/0454 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2004
From: WANG, WEN-CHE; CHEN, HUI-YU; YANG, CHIH-CHIANG
To: PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER
Reel/Frame 015291/0917 →
Priority Claims (1)
TW 93106010 A · Mar 8, 2004 · national
Continuity (1)
Related Publication 20050196438A1 · Sep 8, 2005